FDA
-
-
-
-
-
-
-
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
-
-
-
-
-
-
-
Radiopharm Theranostics increases stake in cancer drug joint venture to 87.5%
-
-
-
-
-
-
-
Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
-
-
-
-
-
-
-
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
-
-
329,909 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

